Ovid Therapeutics
OVID
$3.06
Share price
0.00%
Change (1 day)
-15.70%
Change (1 year)
Categories
P/S ratio for Ovid Therapeutics (OVID)
P/S ratio as of May 2024 (TTM): 553
According to Ovid Therapeutics 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 553.187. At the end of 2023 the company had a P/S ratio of 581.
P/S ratio history for Ovid Therapeutics from 2017 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 581 | 566.19% |
| 2022 | 87.2 | 8215.18% |
| 2021 | 1.05 | -90.97% |
| 2020 | 11.6 | |
| 2019 | N/A | |
| 2018 | N/A | |
| 2017 | N/A |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | N/A | N/A | 🇺🇸 USA |